Articles from 2026
Integrated DNA Technologies Scientists Set New Performance Benchmark for CRISPR Off-Target Nomination
Friday, September 11, 2026
Integrated DNA Technologies (IDT), a Danaher company and a global leader in genomics, announced the publication of a peer-reviewed Nature Communications study establishing a new analytical performance benchmark for CRISPR off-target nomination, providing evidence that can help gene editing developers prioritize biologically relevant sites for downstream confirmation and risk assessment.
Integrated DNA Technologies Defines the Next Era of DNA Synthesis: Full-Spectrum Capabilities for Speed, Complexity and Scale
Friday, September 11, 2026
Integrated DNA Technologies (IDT), a Danaher company and a global leader in genomics, announced it is expanding its DNA synthesis capabilities to support customer needs across yield, complexity, and scale, from rapid production of high-diversity designs in early development, to dependable manufacturing for larger, longer-term programs.
Researchers Gain Faster Access to Complex DNA as Integrated DNA Technologies and Ansa Biotechnologies Expand Ordering Platform
Friday, September 11, 2026
IDT and Ansa expand their partnership to streamline ordering of complex DNA constructs up to 50 kb, giving researchers integrated access to screening, pricing, feasibility insights, and fulfillment options.
SunHydrogen CTO Details Path from Demonstrated Module Performance to Commercialization
Friday, September 11, 2026
SunHydrogen, Inc. (OTCQB: HYSR), the developer of a technology to produce renewable hydrogen using sunlight and water, today released a letter to shareholders from Chief Technology Officer Syed Mubeen covering Austin ProtoHub results, CTF Solar manufacturing, Honda R&D efficiency work, and Sparc Hydrogen collaboration
University of Iowa researchers receive NIH funding to advance potential antioxidant eye treatment
Friday, September 11, 2026
S5G Therapeutics received federal funding from the NIH to advance an antioxidant-based technology that may eventually lead to new eye drop treatments for dry eye disease, Fuchs endothelial corneal dystrophy, and other conditions involving oxidative stress.
NeuroPred Takes Top Prize at 21st John Pappajohn Entrepreneurial Venture Competition
Tuesday, August 25, 2026
NeuroPred, a Coralville-based company spun out of the University of Iowa, took first place and $40,000 at the 21st John Pappajohn Entrepreneurial Venture Competition on Aug. 19 at Iowa State University.
SunHydrogen Modules Exceed 10% Solar-to-Hydrogen Efficiency in Sparc Hydrogen Testing, Advancing to Pilot Scale
Monday, August 17, 2026
SunHydrogen's photoelectrochemical and integrated PV-electrolysis modules reached solar-to-hydrogen efficiency above 10% in testing at Sparc Hydrogen's laboratories and produced more hydrogen under concentrated sunlight; under a new Technology Collaboration and Intellectual Property Protection Agreement, the companies will advance the modules through laboratory and pilot-scale testing at Sparc Hydrogen's SHARP facility in South Australia, followed by a jointly funded techno-economic assessment of hydrogen cost.
Jennifer Meade Appointed President of Integrated DNA Technologies and Aldevron
Wednesday, June 24, 2026
Proven leader to drive sharper execution and faster breakthroughs across research, diagnostics, and advanced therapeutics
Looking to the skies: Eastern Iowa Airport moves to activate aerospace industry cluster
Tuesday, June 23, 2026
A long-simmering plan to develop an aerospace cluster at the Eastern Iowa Airport is nearly ready to come to a full boil.
Pagination